Trial
NCT06425159
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biohaven Therapeutics Ltd.
Collaborators
—
Condition
Generalized Epilepsy
Intervention
BHV-7000
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-24